These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18400444)

  • 1. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
    Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
    Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
    J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY; Hsu CH; Sheu MT
    J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin.
    Stancanelli R; Crupi V; De Luca L; Ficarra P; Ficarra R; Gitto R; Guardo M; Iraci N; Majolino D; Tommasini S; Venuti V
    Bioorg Med Chem; 2008 Sep; 16(18):8706-12. PubMed ID: 18762428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex.
    Granero GE; Maitre MM; Garnero C; Longhi MR
    Eur J Med Chem; 2008 Mar; 43(3):464-70. PubMed ID: 17544174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
    de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
    Zhang M; Li J; Zhang L; Chao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.
    Tommasini S; Calabrò ML; Stancanelli R; Donato P; Costa C; Catania S; Villari V; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):572-80. PubMed ID: 15985355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
    Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.